Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs

被引：180

作者：

Akdis, Cezmi A. ^{[1
,2
]}

Akdis, Muebeccel ^{[1
]}

机构：

[1] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland

[2] Christine Kuhne Ctr Allergy Res & Educ, Davos, Switzerland

来源：

JOURNAL OF CLINICAL INVESTIGATION | 2014年 / 124卷 / 11期

基金：

瑞士国家科学基金会;

关键词：

T-REGULATORY-CELLS; GRASS-POLLEN IMMUNOTHERAPY; TYPE-1; CELLS; BEE VENOM; INDUCTION; RESPONSES; MUCOSAL; ASTHMA; INFLAMMATION; SUPPRESSION;

D O I：

10.1172/JCI78891

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

During the past 20 years, major advances have been made in understanding the molecular and cellular mechanisms of allergen tolerance in humans. The demonstration of T cell tolerance, particularly that mediated by the immune-/ suppressive functions of IL-10, led to a major conceptual change in this area. Currently, the known essential components of allergen tolerance include the induction of allergen-specific regulatory subsets of T and B cells, the immune-suppressive function of secreted factors, such as IL-10 and TGF-beta, the production of IgG4 isotype allergen-specific blocking antibodies, and decreased allergic inflammatory responses by mast cells, basophils, and eosinophils in inflamed tissues.

引用

页码：4678 / 4680

页数：3

共 34 条

[1] Role of interleukin 10 in specific immunotherapy [J].

Akdis, CA ;

Blesken, T ;

Akdis, M ;

Wüthrich, B ;

Blaser, K .

JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (01) :98-106

[2] Epitope-specific T cell tolerance to phospholipase A(2) in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro [J].

Akdis, CA ;

Akdis, M ;

Blesken, T ;

Wymann, D ;

Alkan, SS ;

Muller, U ;

Blaser, K .

JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (07) :1676-1683

[3] Therapies for allergic inflammation: refining strategies to induce tolerance [J].

Akdis, Cezmi A. .

NATURE MEDICINE, 2012, 18 (05) :736-749

[4] Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells [J].

Akdis, M ;

Verhagen, J ;

Taylor, A ;

Karamloo, F ;

Karagiannidis, C ;

Crameri, R ;

Thunberg, S ;

Deniz, G ;

Valenta, R ;

Fiebig, H ;

Kegel, C ;

Disch, R ;

Schmidt-Weber, CB ;

Blaser, K ;

Akdis, CA .

JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (11) :1567-1575

[5] CD4+ T-regulatory cells:: toward therapy for human diseases [J].

Allan, Sarah E. ;

Broady, Raewyn ;

Gregori, Silvia ;

Himmel, Megan E. ;

Locke, Natasha ;

Roncarolo, Maria Grazia ;

Bacchetta, Rosa ;

Levings, Megan K. .

IMMUNOLOGICAL REVIEWS, 2008, 223 :391-421

[6]

[Anonymous], 2008, J ALLERGY CLIN IMMUN

[7]

Bacchetta R, 2002, EUR J IMMUNOL, V32, P2237, DOI 10.1002/1521-4141(200208)32:8<2237::AID-IMMU2237>3.0.CO

[8]

2-2

[9] Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation [J].

Bohle, Barbara ;

Kinaciyan, Tamar ;

Gerstmayr, Marianne ;

Radakovics, Astrid ;

Jahn-Schmid, Beatrice ;

Ebner, Christof .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (03) :707-713

[10] Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report [J].

Burks, A. Wesley ;

Calderon, Moises A. ;

Casale, Thomas ;

Cox, Linda ;

Demoly, Pascal ;

Jutel, Marek ;

Nelson, Harold ;

Akdis, Cezmi A. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (05) :1288-U65

← 1 2 3 4 →